Tinidazole

BreastfeedingPediatric
  • TRADE NAMES: Fasigyn (Pfizer); Tindamax (Mission)
  • INDICATIONS: Amebiasis, giardiasis, trichomoniasis
  • CLASS: Antibiotic, nitroimidazole
  • HALF-LIFE: 12–14 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alcohol, Anticoagulants, Cyclosporine, CYP3A4 inducers or inhibitors, Fluorouracil, Fosphenytoin, Lithium, Phenytoin, Tacrolimus, Typhoid Vaccine, Warfarin

PREGNANCY CATEGORY: C

POTENTIAL RISK FOR CARCINOGENICITY

See full prescribing information for complete boxed warning.

Our database has 42 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
GENITOURINARY
HEMATOLOGIC
NEUROMUSCULAR/SKELETAL
OCULAR
OTHER


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric